The extracellular matrix: A dynamic niche in cancer progression
Open accessThe DOI matches its Crossref record; 143 of the 144 references it cites were found in a registry or an index.
Abstract
The local microenvironment, or niche, of a cancer cell plays important roles in cancer development. A major component of the niche is the extracellular matrix (ECM), a complex network of macromolecules with distinctive physical, biochemical, and biomechanical properties. Although tightly controlled during embryonic development and organ homeostasis, the ECM is commonly deregulated and becomes disorganized in diseases such as cancer. Abnormal ECM affects cancer progression by directly promoting cellular transformation and metastasis. Importantly, however, ECM anomalies also deregulate behavior of stromal cells, facilitate tumor-associated angiogenesis and inflammation, and thus lead to generation of a tumorigenic microenvironment. Understanding how ECM composition and topography are maintained and how their deregulation influences cancer progression may help develop new therapeutic interventions by targeting the tumor niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Besides its biochemical composition, such as intermolecular covalent cross-linkages, the ECM biophysical characteristics include its topography, stiffness/rigidity, molecular density, and tension [118].”
From Tumor microenvironment complexity and therapeutic implications at a glance (2020) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This biochemical framework imparts key biophysical properties to the tumor tissue, including stiffness, porosity, insolubility, and molecular density [5,77,78,79]. These characteristics serve as biomechanical cues that modulate diverse cellular processes, such as migration, proliferation, polarity maintenance, and lineage specification [25,80].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [79]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There is an extensive body of experimental data indicating that remodeling of the ECM promotes cancer invasion and metastasis [42, 43].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“The ECM is known to influence cell behavior in terms of cell migration, and anchorage, by serving as a medium to transmit external forces from environmental cues and even cell signaling throughout the entire lifespan of the cell and at critical phases in their lives [19,20].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [20]
The cited source says what the claim attributes to it.
In the citing paper
“Mechanical properties, e.g., ECM stiffness, of the cell and tissue microenvironment are known to play an important role in cell survival [53,54], proliferation[55], migration[56], and tissue differentiation[57,58].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Self-citationMatrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Self-citationHuman mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
The extracellular matrix at a glance
Frantz, C., Stewart, K. M., & Weaver, V. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.023820 · Cited by 4,334
Self-citationCell Shape, Cytoskeletal Tension, and RhoA Regulate Stem Cell Lineage Commitment
McBeath, R., Pirone, D. M., Nelson, C. M., Bhadriraju, K., & Chen, C. S. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00075-9 · Cited by 4,180
Cited by
Items 901–1,000 of 1,013
Galletti, R., Verger, S., Hamant, O., & Ingram, G. C. (2016) · Development · doi:10.1242/dev.132837 · Cited by 55
“This feedback loop between the ECM and epithelial cells is also very important for tissue adaptation to environmental changes (Lu et al., 2012).”
BackgroundMina, S. G., Huang, P., Murray, B. T., & Mahler, G. J. (2017) · Biomicrofluidics · doi:10.1063/1.4991738 · Cited by 55
LAMB3 mediates metastatic tumor behavior in papillary thyroid cancer by regulating c-MET/Akt signals
Jung, S., Lim, H. S., Liu, L., Chang, J. W., Lim, Y. C., Rha, K., & Koo, B. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21216-0 · Cited by 47
Identification of key genes and miRNAs markers of papillary thyroid cancer
Qiu, J., Zhang, W., Zang, C., Liu, X., Liu, F., Ge, R., Sun, Y., & Xia, Q. (2018) · Biological Research · doi:10.1186/s40659-018-0188-1 · Cited by 47
Cancer Mechanobiology: Microenvironmental Sensing and Metastasis
Lee, G., Han, S., Lee, J., Kim, H., & Kim, D. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01230 · Cited by 52
Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung
Lee, Y., Kurtova, A. V., Xiao, J., Nikolos, F., Hayashi, K., Tramel, Z., Jain, A., Chen, F., Chokshi, M., Lee, C. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09878-4 · Cited by 54
Romero-Cordoba, S. L., Meneghini, E., Sant, M., Iorio, M. V., Sfondrini, L., Paolini, B., Agresti, R., Tagliabue, E., & Bianchi, F. (2019) · Cancers · doi:10.3390/cancers11070911 · Cited by 50
PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression
Gagliano, T., Shah, K., Gargani, S., Lao, L., Alsaleem, M. A., Chen, J., Ntafis, V., Huang, P., Ditsiou, A., Vella, V., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128313 · Cited by 50
“Therefore, we focused on fibroblasts, the main stromal component in the TME, whose multiplex role in BC initiation, progression and therapy-resistance has been well described (7, 13, 14).”
BackgroundRoy, S. M., Garg, V., Barman, S., Ghosh, C., Maity, A. R., & Ghosh, S. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.785937 · Cited by 54
Oncobiology and treatment of breast cancer in young women
Kumar, R., Abreu, C., Toi, M., Saini, S., Casimiro, S., Arora, A., Paul, A. M., Velaga, R., Rameshwar, P., Lipton, A., et al. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10034-6 · Cited by 51
“Since the processes of involution and wound healing share several features of the pro-tumorigenic and inflammatory microenvironment phenotypes [106, 110, 111], exposure of tumor cells to fibrillar collagen and proinflammatory cyclooxygenase 2 has been proposed as the possible mechanism of PPBC development in young wom…”
BackgroundThe origins of the molecular era of adhesion research
Horwitz, A. R. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3473 · Cited by 47
Yoon, A. R., Hong, J., Kim, S. W., & Yun, C. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1158707 · Cited by 49
Hui, L., Zhang, J., Ding, X., Guo, X., & Jiang, X. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3877 · Cited by 56
“Recently studies reported that tumor growth and metastasis are affected by both biochemical and physical properties of the tumor microenvironment (4-8).”
Turetta, M., Ben, F. D., Brisotto, G., Biscontin, E., Bulfoni, M., Cesselli, D., Colombatti, A., Scoles, G., Gigli, G., & del Mercato, L. L. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180605122633 · Cited by 50
“moting cancer cell transformation and metastasis [123,124].”
The Role of Oncolytic Viruses in the Treatment of Melanoma
Bayan, C.-A. Y., Lopez, A. T., Gartrell, R. D., Komatsubara, K. M., Bogardus, M. H., Rao, N., Chen, C., Hart, T. D., Enzler, T., Rizk, E. M., et al. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0729-3 · Cited by 49
Tokarz, D., Cisek, R., Joseph, A., Golaraei, A., Mirsanaye, K., Kruglov, S. I., Asa, S. L., Wilson, B. C., & Barzda, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00272 · Cited by 49
“During cancer initiation and progression, mechanisms responsible for ensuring normal organ development and function are deregulated, leading to ECM disorganization (8), so that a technique that identifies and quantifies structural details in the ECM as well as permits the distinction of cells present in the ECM would…”
BackgroundLee, E. J., & Chang, Y. (2020) · Korean Journal of Radiology · doi:10.3348/kjr.2019.0765 · Cited by 46
Vohra, M., Sharma, A. R., Prabhu, N. B., & Padmalatha, S. (2020) · Public Health Genomics · doi:10.1159/000510253 · Cited by 56
Distinct extracellular–matrix remodeling events precede symptoms of inflammation
Shimshoni, E., Adir, I., Afik, R., Solomonov, I., Shenoy, A., Adler, M., Puricelli, L., Sabino, F., Savickas, S., Mouhadeb, O., et al. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.11.001 · Cited by 44
O’Melia, M. J., Rohner, N. A., Manspeaker, M. P., Francis, D. M., Kissick, H. T., & Thomas, S. N. (2020) · Science Advances · doi:10.1126/sciadv.abd7134 · Cited by 50
Microwave-assisted methacrylation of chitosan for 3D printable hydrogels in tissue engineering
Zanon, M., Chiappone, A., Garino, N., Canta, M., Frascella, F., Hakkarainen, M., Pirri, C. F., & Sangermano, M. (2021) · Materials Advances · doi:10.1039/d1ma00765c · Cited by 50
More than a scaffold: Stromal modulation of tumor immunity
Johansson, A., Hamzah, J., & Ganß, R. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.001 · Cited by 49
“Moreover, ECM is also a highly dynamic structurewhich changes during normal tissue remodeling and inflammation [47].”
The influence of pH and hypoxia on tumor metastasis
Abaza, M., & Luqmani, Y. A. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2013.843455 · Cited by 49
Clément, V., Roy, V., Paré, B., Goulet, C. R., Touzel‐Deschênes, L., Berthod, F., Bolduc, S., & Gros‐Louis, F. (2022) · Scientific Reports · doi:10.1038/s41598-022-23433-0 · Cited by 52
Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy
Borst, R., Meyaard, L., & Ramos, M. I. P. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05199-3 · Cited by 55
“The ECM also influences the migration of immune cells that promote or prevent tumor growth, depending on tumor type and disease stage [7, 9, 18, 19].”
BackgroundCrosstalk between Epithelial and Mesenchymal Tissues in Tumorigenesis and Imaginal Disc Development
Herranz, H., Weng, R., & Cohen, S. M. (2014) · Current Biology · doi:10.1016/j.cub.2014.05.043 · Cited by 51
Core-shell hydrogel beads with extracellular matrix for tumor spheroid formation
Yu, L., Grist, S. M., Nasseri, S. S., Cheng, E., Hwang, Y.-C. E., Ni, C., & Cheung, K. C. (2015) · Biomicrofluidics · doi:10.1063/1.4918754 · Cited by 55
LRG1 is an independent prognostic factor for endometrial carcinoma
Wen, S.-Y., Zhang, L., Yang, X., Zhang, Y., Ma, L., Ge, Q., Jiang, S., Zhu, X., Xu, W., Ding, W.-J., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-1953-6 · Cited by 45
“, are closely correlated with the progression and prognosis of malignant tumor [3, 4].”
BackgroundMiniaturized pre-clinical cancer models as research and diagnostic tools
Håkanson, M., Cukierman, E., & Charnley, M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.010 · Cited by 45
p53 regulates epithelial–mesenchymal transition induced by transforming growth factor β
Termén, S., Tan, E., Heldin, C., & Moustakas, A. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24229 · Cited by 47
FTIR microspectroscopy of selected rare diverse sub‐variants of carcinoma of the urinary bladder
Hughes, C. S., Iqbal‐Wahid, J., Brown, M. D., Shanks, J. H., Eustace, A., Denley, H., Hoskin, P., West, C., Clarke, N. W., & Gardner, P. (2012) · Journal of Biophotonics · doi:10.1002/jbio.201200126 · Cited by 46
Therapeutic targeting of platelet-derived growth factor receptors in solid tumors
Ehnman, M., & Östman, A. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.847086 · Cited by 46
“A supportive role of cancerassociated fibroblasts (CAFs) and tumor stroma has been verified in different types of mouse cancer models [62-64].”
BackgroundThe association between laminin and microglial morphology in vitro
Tam, W. Y., Au, N. P. B., & Ma, C. H. E. (2016) · Scientific Reports · doi:10.1038/srep28580 · Cited by 49
Mali, A. V., Joshi, A., Hegde, M. V., & Kadam, S. S. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.4.905 · Cited by 50
“It is now well accepted fact that an abnormal ECM influences cancer progression by directly promoting cellular transformation and metastasis (Lu et al., 2012).”
BackgroundPhagocyte—extracellular matrix crosstalk empowers tumor development and dissemination
Varol, C., & Sagi, I. (2017) · FEBS Journal · doi:10.1111/febs.14317 · Cited by 50
Targeting UDP-α-d-glucose 6-dehydrogenase inhibits glioblastoma growth and migration
Oyinlade, O., Wei, S., Lal, B., Laterra, J., Zhu, H., Goodwin, C. R., Wang, S., Ma, D., Wan, J., & Xia, S. (2018) · Oncogene · doi:10.1038/s41388-018-0138-y · Cited by 45
“which promotes cell cycle progression and cell proliferation, while also functioning as either a barrier or a movement track to inhibit or promote cell migration [5].”
BackgroundClinical doses of radiation reduce collagen matrix stiffness
Miller, J. P., Borde, B. H., Bordeleau, F., Zanotelli, M. R., LaValley, D. J., Parker, D. J., Bonassar, L. J., Pannullo, S. C., & Reinhart‐King, C. A. (2018) · APL Bioengineering · doi:10.1063/1.5018327 · Cited by 50
Traction Force Microscopy for Noninvasive Imaging of Cell Forces
Mulligan, J. A., Bordeleau, F., Reinhart‐King, C. A., & Adie, S. G. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95294-9_15 · Cited by 47
“(Collagen and fibronectin, which are among the most abundant ECM components found in tumors [51-53], are often used for this purpose.”
BackgroundXiao, M., Li, X., Song, Q., Zhang, Q., Lazzarino, M., Cheng, G., Severino, F. P. U., & Torre, V. (2018) · Advanced Materials · doi:10.1002/adma.201806132 · Cited by 48
Enhanced nanoparticle delivery exploiting tumour-responsive formulations
Bennie, L. A., McCarthy, H. O., & Coulter, J. A. (2018) · Cancer Nanotechnology · doi:10.1186/s12645-018-0044-6 · Cited by 50
Shan, M., Dai, D. L., Vudem, A., Varner, J. D., & Stroock, A. D. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006584 · Cited by 56
Gruber, E. J., & Leifer, C. A. (2020) · Innate Immunity · doi:10.1177/1753425919838322 · Cited by 45
Vasiukov, G., Novitskaya, T., Zijlstra, A., Owens, P., Ye, F., Zhao, Z., Moses, H. L., Blackwell, T. S., Feoktistov, I., & Novitskiy, S. V. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3954 · Cited by 45
MR Elastography of the Breast: Evolution of Technique, Case Examples, and Future Directions
Patel, B., Samreen, N., Zhou, Y., Chen, J., Brandt, K. R., Ehman, R. L., & Pepin, K. M. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.08.005 · Cited by 51
Duran-Sierra, E., Cheng, S., Cuenca, R., Ahmed, B., Ji, J., Yakovlev, V. V., Martinez, M., Al-Khalil, M., Al-Enazi, H., Cheng, Y. L., et al. (2021) · Cancers · doi:10.3390/cancers13194751 · Cited by 45
“connective tissue [31,32] and increased epithelial thickness and tissue optical scattering, which are characteristic of premalignant and malignant oral tissue transformation [33].”
BackgroundPan-Cancer analysis of the expression and regulation of matrisome genes across 32 tumor types
Izzi, V., Lakkala, J., Devarajan, R., Kääriäinen, A., Koivunen, J. T., Heljäsvaara, R., & Pihlajaniemi, T. A. (2019) · Matrix Biology Plus · doi:10.1016/j.mbplus.2019.04.001 · Cited by 43
“in the case of collagen I, II, III, V and IX deposition in a vast array of solid tumors [12,13] and impaired laminin adhesion in breast and lung cancer [14,15].”
BackgroundShah, L., Latif, A., Williams, K. J., & Tirella, A. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.074 · Cited by 48
“Most solid tumours like breast cancer have increased stiffness than the adjoining normal tissue, as well as a state of fibrosis known as ‘desmoplasia’ [18] .”
The role of matrix stiffness in breast cancer progression: a review
Xu, R., Yin, P., Wei, J., & Ding, Q. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1284926 · Cited by 56
“One of the most obvious signs of breast cancer is tissue hardening, which can be detected by palpating malignant nodules (1, 2).”
BackgroundOXPHOS dysfunction regulates integrin- 1 modifications and enhances cell motility and migration
Nunes, J. B., Peixoto, J., Soares, P., Máximo, V., Carvalho, S., Pinho, S. S., Vieira, A. F., Paredes, J., Rego, A. C., Ferreira, I. L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu612 · Cited by 45
Xing, X., Gu, X., & Ma, T. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4383 · Cited by 44
Pearson, J. R., Zurita, F., Tomás‐Gallardo, L., Díaz-Torres, A., de la Loza, M. D. C. D., Franze, K., Martin-Bermudo, M. D., & González‐Reyes, A. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005763 · Cited by 49
“The extracellular matrix (ECM) is an essential component of adult stem cell niches, and hence a fundamental player in tissue homeostasis, as it regulates stem cell fate by mediating signal delivery and by providing matrix-directed differentiation [1, 2].”
BackgroundDesigner Extracellular Matrix Based on DNA–Peptide Networks Generated by Polymerase Chain Reaction
Finke, A., Bußkamp, H., Manea, M., & Marx, A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201604687 · Cited by 45
Cramer, G. M., Jones, D. P., El-Hamidi, H., & Celli, J. P. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0260 · Cited by 48
“or PDT; and (5) imaging-based assesment of therapeutic response,”
Mechanosensitive adhesion complexes in epithelial architecture and cancer onset
Bosch‐Fortea, M., & Martín‐Belmonte, F. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.01.013 · Cited by 49
Totti, S., Allenby, M. C., Santos, S. B. D., Mantalaris, A., & Velliou, E. G. (2018) · RSC Advances · doi:10.1039/c8ra02633e · Cited by 47
Harnessing Tumor Microenvironment for Nanoparticle‐Mediated Radiotherapy
Zhu, S., Gu, Z., & Zhao, Y. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800050 · Cited by 44
Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells
Sampayo, R. G., Toscani, A. M., Rubashkin, M. G., Thi, K., Masullo, L. A., Violi, I. L., Lakins, J. N., Cáceres, A., Hines, W. C., Leskow, F. C., et al. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201703037 · Cited by 48
Self-citationRecent advances in tumor microenvironment associated therapeutic strategies and evaluation models
Haider, T., Sandha, K. K., Soni, V., & Gupta, P. N. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.111229 · Cited by 45
Cancer associated talin point mutations disorganise cell adhesion and migration
Azizi, L., Cowell, A. R., Mykuliak, V. V., Goult, B. T., Turkki, P., & Hytönen, V. P. (2021) · Scientific Reports · doi:10.1038/s41598-020-77911-4 · Cited by 46
Cells nanomechanics by atomic force microscopy: focus on interactions at nanoscale
Zhou, G., Zhang, B., Tang, G., Yu, X., & Galluzzi, M. (2021) · Advances in Physics X · doi:10.1080/23746149.2020.1866668 · Cited by 54
Wang, J., Chen, C., Wang, L., Xie, M., Ge, X., Wu, S., He, Y., Mou, X., Ye, C., & Sun, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.872531 · Cited by 52
“Adding Extracellular Matrix The in vivo ECM is a dynamic polymer network that not only provides structural support but also delivers biochemical signaling cues (62, 63).”
BackgroundOverexpression and β-1,6-N-Acetylglucosaminylation-initiated Aberrant Glycosylation of TIMP-1
Kim, Y.-S., Ahn, Y. H., Song, K. J., Kang, J. G., Lee, J. H., Jeon, S. K., Kim, H.-C., Yoo, J. S., & Ko, J.-H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.370064 · Cited by 44
“Recently,mounting evidence has highlighted the importance of ECM during cancer development and progression (6, 7).”
BackgroundMolecular imaging to enlighten cancer immunotherapies and underlying involved processes
van der Veen, E. L., Bensch, F., Glaudemans, A. W. J. M., Hooge, M. N. L., & de Vries, E. G. E. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.09.007 · Cited by 46
Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma
Cescon, M., Rampazzo, E., Bresolin, S., Ros, F. D., Manfreda, L., Cani, A., Puppa, A. D., Braghetta, P., Bonaldo, P., & Persano, L. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04887-5 · Cited by 45
“Within tumor microenvironment, the extracellular matrix (ECM) plays multiple key roles by shaping stem cell niches [9], modulating growth factors availability [10], mediating specific ECM-dependent pro-survival signaling cascades [11], influencing tumor invasiveness [12] and response to chemotherapy [13], and even pro…”
BackgroundHo, K., Poon, P. C., Owen, S. C., & Shoichet, M. S. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-579 · Cited by 52
“The basement membrane forms a physical barrier that inhibits transport of high molecular weight materials across blood vessel walls [15,32].”
BackgroundExpression level and glycan dynamics determine the net effects of TIMP-1 on cancer progression
Kim, Y. S., Kim, S. H., Kang, J. G., & Ko, J. H. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.11.233 · Cited by 46
“Evidence is accumulating that indicates the important role of ECM in cancer development and progression (33-35).”
BackgroundAppunni, S., Anand, V., Khandelwal, M., Seth, A., Mathur, S. R., & Sharma, A. (2017) · Tumor Biology · doi:10.1177/1010428317699112 · Cited by 47
Katara, G. K., Kulshrestha, A., Mao, L., Wang, X., Sahoo, M., Ibrahim, S. A.-S., Pamarthy, S., Suzue, K., Shekhawat, G. S., Gilman‐Sachs, A., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12159 · Cited by 50
“In cancer, ECM architecture can influence disease outcome before and during the disease conditions (Lu et al., 2012).”
BackgroundThe Cdx2 homeobox gene suppresses intestinal tumorigenesis through non–cell-autonomous mechanisms
Balbinot, C., Armant, O., Elarouci, N., Marisa, L., Martin, E., Clara, E. D., Onéa, A., Deschamps, J., Beck, F., Freund, J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170934 · Cited by 56
Obstacles to T cell migration in the tumor microenvironment
Nicolas-Boluda, A., & Donnadieu, E. (2019) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2018.12.006 · Cited by 43
Mechanobiology of Cancer Stem Cells and Their Niche
Choudhury, A. R., Gupta, S., Chaturvedi, P. K., Kumar, N., & Pandey, D. (2019) · Cancer Microenvironment · doi:10.1007/s12307-019-00222-4 · Cited by 48
Girish, C. M., Iyer, S., Thankappan, K., Gowd, G. S., Nair, S. V., & Koyakutty, M. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801557 · Cited by 43
The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment
Ducimetière, L., Vermeer, M., & Tugues, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02895 · Cited by 51
“During cancer progression, the deregulation of the ECM promotes invasion, angiogenesis and facilitates immune cell infiltration (109).”
BackgroundTargeting the lysyl oxidases in tumour desmoplasia
Chitty, J. L., Setargew, Y. F. I., & Cox, T. R. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190098 · Cited by 42
Leiva, M. C., Garré, E., Gustafsson, A., Svanström, A., Bogestål, Y. R., Håkansson, J., Ståhlberg, A., & Landberg, G. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30191 · Cited by 42
“Even though most cancer studies are based on analyses of tumor cells, the microenvironment has been suggested to substantially influence tumor progression and malignancy (Lu et al., 2012).”
BackgroundHydrogels to engineer tumor microenvironments in vitro
Fernando, K., Kwang, L. G., Lim, J. T. C., & Fong, E. L. S. (2021) · Biomaterials Science · doi:10.1039/d0bm01943g · Cited by 48
Modeling the Mechanobiology of Cancer Cell Migration Using 3D Biomimetic Hydrogels
Morales, X., Cortés‐Domínguez, I., & Ortíz-de-Solórzano, C. (2021) · Gels · doi:10.3390/gels7010017 · Cited by 49
“Similarly, high level of collagen cross‐linking by LOX overex‐ pression promotes integrin recruitment, FAs assembly, and strong tensile forces that trig‐ ger the oncogenic transformation and tumor dissemination [109].”
BackgroundExtracellular Matrix-Based Hydrogels to Tailoring Tumor Organoids
Lee, H. J., Mun, S., Pham, D. M., & Kim, P. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01801 · Cited by 47
Autophagy: A promising target for triple negative breast cancers
El-Aziz, Y. S. A., Gillson, J., Jansson, P. J., & Sahni, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106006 · Cited by 47
Scherzer, M. T., Waigel, S. J., Donninger, H., Arumugam, V., Zacharias, W., Clark, G., Siskind, L. J., Soucy, P. A., & Beverly, L. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138065 · Cited by 48
“Lately, the ECM has been heavily researched for its role in the progression of lung and breast carcinomas [5, 6].”
BackgroundWeaving the nest: extracellular matrix roles in pre-metastatic niche formation
Pătraș, L., Paul, D., & Matei, I. R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1163786 · Cited by 48
“, pancreatic cancer (99)) and confer a fibrotic state due to increased ECM deposition and enhanced PTMs of ECM proteins (100).”
BackgroundCancer-associated fibroblast-derived exosome microRNA-21 promotes angiogenesis in multiple myeloma
Sun, M., Xiao-qian, W., Shou, Y., Chao, C., Yang, C., Liang, Y., Hong, Y., Jiao, S., & Kuisheng, C. (2023) · Scientific Reports · doi:10.1038/s41598-023-36092-6 · Cited by 48
Intra-tumor heterogeneity: lessons from microbial evolution and clinical implications
de Bruin, E. C., Taylor, T., & Swanton, C. (2013) · Genome Medicine · doi:10.1186/gm505 · Cited by 45
Association of MMP7 −181A→G Promoter Polymorphism with Gastric Cancer Risk
Kesh, K., Subramanian, L., Ghosh, N., Gupta, V., Gupta, A., Bhattacharya, S., Mahapatra, N. R., & Swarnakar, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.630129 · Cited by 42
Expression of COL6A1 predicts prognosis in cervical cancer patients.
Hou, T., Tong, C., Kazobinka, G., Zhang, W., Huang, X., Huang, Y., & Zhang, Y. (2016) · Europe PMC (PubMed Central) · Cited by 50
Agrin has a pathological role in the progression of oral cancer
Rivera, C., Zandonadi, F. D. S., Sánchez‐Romero, C., Soares, C. D., Granato, D. C., González‐Arriagada, W. A., & Leme, A. F. P. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0135-5 · Cited by 44
“Some components of the ECM, which include heparan sulphate proteoglycans, are frequently overproduced in cancer.(8) Agrin is one of the main heparan sulphate proteoglycans present in the ECM.”
BackgroundKane, K. I. W., Moreno, E. L., Lehr, C. M., Hachi, S., Dannert, R., Sanctuary, R., Wagner, C., Fleming, R. M. T., & Baller, J. (2018) · AIP Advances · doi:10.1063/1.5067382 · Cited by 50
Miki, F., Maruyama, T., Miyazaki, K., Takao, T., Yoshimasa, Y., Katakura, S., Hihara, H., Uchida, S., Masuda, H., Uchida, H., et al. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz004 · Cited by 42
Stroma in normal and cancer wound healing
Huet, E., Jaroz, C., Nguyen, H. Q., Belkacemi, Y., de la Taille, A., Stavrinides, V., & Whitaker, H. (2019) · The FEBS Journal · doi:10.1111/febs.14842 · Cited by 42
Wang, M., Su, Z., & Barnie, P. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106298 · Cited by 46
Mechanobiology of Autophagy: The Unexplored Side of Cancer
Hernández‐Cáceres, M. P., Munoz, L., Pradenas, J., Pena, F., Lagos, P., Aceitón, P., Owen, G. I., Morselli, E., Criollo, A., Ravasio, A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.632956 · Cited by 46
“Extracellular matrix stiffening in tumors is produced as consequence of stroma reorganization, through the excessive activity of extracellular matrix proteins and enzymes that covalently cross-link collagen fibers and other extracellular matrix components [237,238].”
BackgroundRahmanian, M., Seyfoori, A., Ghasemi, M., Shamsi, M., Kolahchi, A. R., Modarres, H. P., Sanati‐Nezhad, A., & Majidzadeh‐A, K. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.024 · Cited by 42
Wang, S., Sun, Y., Li, R., Mao, N., Li, Q., Jiang, T., Chen, Q., Duan, S., Xie, H., & Gu, Y. (2021) · European Radiology · doi:10.1007/s00330-021-08134-y · Cited by 51
Sequential Intra‐Intercellular Nanoparticle Delivery System for Deep Tumor Penetration
Ju, C., Mo, R., Xue, J., Zhang, L., Zhao, Z., Xue, L., Ping, Q., & Zhang, C. (2014) · Angewandte Chemie · doi:10.1002/ange.201311227 · Cited by 46
Ratliff, M., Kim, H., Qi, H., Kim, M., Ku, B., Azorín, D. D., Hausmann, D., Khajuria, R. K., Patel, A., Maier, E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126572 · Cited by 46
Lee, M. W., Downes, A., Chau, Y.-Y., Serrels, B., Hastie, N. D., Elfick, A. P. D., Brunton, V. G., Frame, M. C., & Serrels, A. (2015) · IntraVital · doi:10.1080/21659087.2015.1055430 · Cited by 44
“It has been shown that tumor cells are extensively involved in re-modeling the extracellular matrix.(30) We observed marked changes in the collagen abundance and orientation within the tumor (Fig.”
BackgroundTsao, C.-T., Kievit, F. M., Wang, K., Erickson, A. E., Ellenbogen, R. G., & Zhang, M. (2014) · Molecular Pharmaceutics · doi:10.1021/mp5002119 · Cited by 45
Ogut, D., Reel, B., Korkmaz, C. G., Arun, M. Z., Mıçılı, S. Ç., & Ergür, B. U. (2016) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2016.0022 · Cited by 41
Willumsen, N., Bager, C. L., Leeming, D. J., Bay‐Jensen, A., & Karsdal, M. A. (2017) · Neoplasia · doi:10.1016/j.neo.2017.01.008 · Cited by 43
“Disruption of the healthy tissue homeostasis and altered turnover of the ECM are hallmarks of cancer and lead to progression of the disease [1].”
Multifaceted Roles of Asporin in Cancer: Current Understanding
Zhan, S., Li, J., & Ge, W. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00948 · Cited by 42
“Although non-drugs are currently in clinical trials for the treatment of patients with asporin dysregulation cancers, there are several potential strategies to reduce asporin functional dose in future cancer studies: (1) inhibition of asporin protein-protein interactions; (2) targeting asporin mRNA.”
Background
Metadata
- Authors
- Lu, P., Weaver, V. M., & Werb, Z.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Werb, Zena
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2012-02-20
- Volume
- 196
- Issue
- 4
- Pages
- 395-406
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3283993
- OpenAlex
- W2132566055
- Semantic Scholar
- 3fca40f6a3c524e3208a0f95c34cd67f453bae03
- Cited by
- 3,024
- References
- 144
- Citations by year
- 2026: 136 · 2025: 155 · 2024: 155 · 2023: 214 · 2022: 207 · 2021: 290 · 2020: 284 · 2019: 268 · 2018: 275 · 2017: 251 · 2016: 254 · 2015: 191 · 2014: 180 · 2013: 117 · 2012: 43
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA138818, P50CA058207, R01CA057621)
- National Institute of Environmental Health Sciences (U01ES019458)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R03HD060807)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- extracellular matrix, tumor microenvironment, tumor progression, metastasis, cell transformation, stromal cells, tumor angiogenesis, inflammation, ECM composition, ECM-targeted therapy
- MeSH terms
- Extracellular Matrix, Humans, Neoplasms, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.